Evaluation of nevirapine dosing recommendations in HIV-infected children-Reference-Cited by-同舟云学术

Evaluation of nevirapine dosing recommendations in HIV-infected children

Published:2013-06-20 Issue:1 Volume:76 Page:137-144
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Foissac Frantz,Bouazza Naïm,Frange Pierre,Blanche Stéphane,Faye Albert,Lachassinne Eric¹,Dollfus Catherine²,Hirt Déborah,Benaboud Sihem,Treluyer Jean-Marc,Urien Saïk

Affiliation:

1. Service de Pédiatrie, Hôpital Jean Verdier, AP-HP; Paris; France

2. Service d'Hématologie et d'oncologie pédiatrique, Hôpital Trousseau, AP-HP; Paris; France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12069/fullpdf

Reference34 articles.

1. Viramune: EPAR product information;European Medicines Agency;European Medicines Agency,2011

2. Pharmacokinetics, safety, and activity of nevirapine in human immunodeficiency virus type 1-infected children;Luzuriaga;J Infect Dis,1996

3. Nevirapine use in HIV-1-infected children;Verweel;AIDS,2003

4. Population pharmacokinetics of nevirapine in HIV-1-infected pregnant women and their neonates;Benaboud;Antimicrob Agents Chemother,2011

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is Routine Therapeutic Drug Monitoring of Anti-Retroviral Agents Warranted in Children Living with HIV?;The Journal of Pediatric Pharmacology and Therapeutics;2022-07-01

2. High nevirapine levels in breast milk and consequences in HIV-infected child when initiated on antiretroviral therapy;AIDS;2021-11-15

3. Scale-up of Kenya’s national HIV viral load program: Findings and lessons learned;PLOS ONE;2018-01-11

4. Assessment of Nevirapine Prophylactic and Therapeutic Dosing Regimens for Neonates;JAIDS Journal of Acquired Immune Deficiency Syndromes;2017-08-15

5. Controlling Antiretroviral Therapy in Children and Adolescents with HIV Infection;Individualized Drug Therapy for Patients;2017